Questionable levels of evidence in new atrial fibrillation guidelines?

Author： Van Brabandt Hans   Neyt Mattias   Devos Carl  

Publisher： Oxford University Press

ISSN： 1099-5129

Source： EP-Europace, Vol.15, Iss.3, 2013-03, pp. : 461-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Questionable levels of evidence in new atrial fibrillation guidelines? Reply

By Camm A.J.   Lip G.Y.   De Caterina R.   Savelieva I.   Atar D.   Hohnloser S.H.   Hindricks G.   Kirchhof P.  

EP-Europace, Vol. 15, Iss. 3, 2013-03 ,pp. : 461-462

Oxford University Press

Access to resources Recommend Favorite

Colchicine for Postoperative Atrial Fibrillation Prevention: Is Its Efficacy Questionable?

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 239-240

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy for atrial fibrillation: new challenges

By Shantsila Eduard   Watson Timothy   Lip Gregory YH  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 445-448

Future Medicine

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation

By Choudhury Anirban   Lip Gregory YH  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 111-121

Future Medicine

Access to resources Recommend Favorite

New antiarrhythmic drugs for atrial fibrillation

By  

Continuing Cardiology Education, Vol. 2, Iss. 3, 2016-09 ,pp. : 151-157

John Wiley & Sons Inc

Access to resources Recommend Favorite